Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid ...

Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies: Turku, Finland Wednesday, May 28, 2025, 16:00 Hrs [IST] Faron ...

TURKU, FI / ACCESS Newswire / May 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - New preclinical data published in Scientific Reports confirms CLEVER-1 inhibition by Bexmarilimab increases a ...

Roles of CCL2 and CCR2 in T cell differentiation The highlighted studies ... The activity of chemokines in inducing activation of myeloid cells is well established 38 and chemokine-mediated ...

A National Institutes of Health (NIH)-funded study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg ...

A study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg School of Public Health and The Johns Hopkins ...

Changes in blood are detectable at age 50 and universal by 60, paving the way for spotting early signs of unhealthy aging.